vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and TSS, Inc. (TSSI). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $60.9M, roughly 1.4× TSS, Inc.). TSS, Inc. runs the higher net margin — 20.0% vs -38.1%, a 58.0% gap on every dollar of revenue. On growth, TSS, Inc. posted the faster year-over-year revenue change (21.8% vs 20.2%). Over the past eight quarters, TSS, Inc.'s revenue compounded faster (95.8% CAGR vs 24.8%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

PRCT vs TSSI — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.4× larger
PRCT
$83.1M
$60.9M
TSSI
Growing faster (revenue YoY)
TSSI
TSSI
+1.6% gap
TSSI
21.8%
20.2%
PRCT
Higher net margin
TSSI
TSSI
58.0% more per $
TSSI
20.0%
-38.1%
PRCT
Faster 2-yr revenue CAGR
TSSI
TSSI
Annualised
TSSI
95.8%
24.8%
PRCT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PRCT
PRCT
TSSI
TSSI
Revenue
$83.1M
$60.9M
Net Profit
$-31.6M
$12.2M
Gross Margin
64.9%
17.6%
Operating Margin
-4.1%
1.5%
Net Margin
-38.1%
20.0%
Revenue YoY
20.2%
21.8%
Net Profit YoY
-27.9%
535.7%
EPS (diluted)
$-0.56
$0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
TSSI
TSSI
Q1 26
$83.1M
Q4 25
$76.4M
$60.9M
Q3 25
$83.3M
$41.9M
Q2 25
$79.2M
$44.0M
Q1 25
$69.2M
$99.0M
Q4 24
$68.2M
$50.0M
Q3 24
$58.4M
$70.1M
Q2 24
$53.4M
$12.2M
Net Profit
PRCT
PRCT
TSSI
TSSI
Q1 26
$-31.6M
Q4 25
$-29.8M
$12.2M
Q3 25
$-21.4M
$-1.5M
Q2 25
$-19.6M
$1.5M
Q1 25
$-24.7M
$3.0M
Q4 24
$-18.9M
$1.9M
Q3 24
$-21.0M
$2.6M
Q2 24
$-25.6M
$1.4M
Gross Margin
PRCT
PRCT
TSSI
TSSI
Q1 26
64.9%
Q4 25
60.6%
17.6%
Q3 25
64.8%
11.1%
Q2 25
65.4%
17.8%
Q1 25
63.9%
9.3%
Q4 24
64.0%
14.4%
Q3 24
63.2%
11.3%
Q2 24
59.0%
37.3%
Operating Margin
PRCT
PRCT
TSSI
TSSI
Q1 26
-4.1%
Q4 25
-40.6%
1.5%
Q3 25
-27.8%
-2.2%
Q2 25
-28.0%
5.1%
Q1 25
-39.7%
4.2%
Q4 24
-28.9%
0.0%
Q3 24
-38.4%
5.4%
Q2 24
-50.3%
14.0%
Net Margin
PRCT
PRCT
TSSI
TSSI
Q1 26
-38.1%
Q4 25
-39.1%
20.0%
Q3 25
-25.7%
-3.6%
Q2 25
-24.7%
3.4%
Q1 25
-35.8%
3.0%
Q4 24
-27.6%
3.8%
Q3 24
-35.9%
3.8%
Q2 24
-48.0%
11.5%
EPS (diluted)
PRCT
PRCT
TSSI
TSSI
Q1 26
$-0.56
Q4 25
$-0.54
$0.44
Q3 25
$-0.38
$-0.06
Q2 25
$-0.35
$0.06
Q1 25
$-0.45
$0.12
Q4 24
$-0.34
$0.08
Q3 24
$-0.40
$0.10
Q2 24
$-0.50
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
TSSI
TSSI
Cash + ST InvestmentsLiquidity on hand
$245.6M
$85.5M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
$76.6M
Total Assets
$487.1M
$184.9M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
TSSI
TSSI
Q1 26
$245.6M
Q4 25
$286.5M
$85.5M
Q3 25
$294.3M
$70.7M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
$23.2M
Q3 24
$196.8M
$46.4M
Q2 24
$214.1M
$8.3M
Total Debt
PRCT
PRCT
TSSI
TSSI
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
TSSI
TSSI
Q1 26
$347.7M
Q4 25
$365.9M
$76.6M
Q3 25
$380.3M
$63.4M
Q2 25
$385.8M
$9.5M
Q1 25
$389.2M
$9.4M
Q4 24
$402.2M
$7.1M
Q3 24
$241.2M
$7.7M
Q2 24
$251.8M
$5.2M
Total Assets
PRCT
PRCT
TSSI
TSSI
Q1 26
$487.1M
Q4 25
$508.1M
$184.9M
Q3 25
$511.5M
$165.4M
Q2 25
$513.1M
$139.5M
Q1 25
$519.4M
$113.5M
Q4 24
$534.0M
$96.6M
Q3 24
$374.1M
$67.3M
Q2 24
$374.4M
$28.9M
Debt / Equity
PRCT
PRCT
TSSI
TSSI
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
TSSI
TSSI
Operating Cash FlowLast quarter
$16.3M
Free Cash FlowOCF − Capex
$15.8M
FCF MarginFCF / Revenue
25.9%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
1.34×
TTM Free Cash FlowTrailing 4 quarters
$2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
TSSI
TSSI
Q1 26
Q4 25
$-10.3M
$16.3M
Q3 25
$-6.6M
$-18.4M
Q2 25
$-15.0M
$16.3M
Q1 25
$-17.0M
$20.6M
Q4 24
$-32.4M
$-21.6M
Q3 24
$-18.8M
$38.6M
Q2 24
$-15.7M
$-4.3M
Free Cash Flow
PRCT
PRCT
TSSI
TSSI
Q1 26
Q4 25
$-12.2M
$15.8M
Q3 25
$-9.5M
$-24.9M
Q2 25
$-17.8M
$5.4M
Q1 25
$-18.8M
$5.8M
Q4 24
$-33.6M
$-28.4M
Q3 24
$-19.0M
$38.6M
Q2 24
$-16.8M
$-6.0M
FCF Margin
PRCT
PRCT
TSSI
TSSI
Q1 26
Q4 25
-15.9%
25.9%
Q3 25
-11.4%
-59.3%
Q2 25
-22.5%
12.3%
Q1 25
-27.2%
5.8%
Q4 24
-49.2%
-56.7%
Q3 24
-32.6%
55.1%
Q2 24
-31.4%
-49.4%
Capex Intensity
PRCT
PRCT
TSSI
TSSI
Q1 26
Q4 25
2.4%
0.9%
Q3 25
3.4%
15.3%
Q2 25
3.5%
24.8%
Q1 25
2.7%
15.0%
Q4 24
1.7%
13.4%
Q3 24
0.4%
0.1%
Q2 24
2.0%
13.8%
Cash Conversion
PRCT
PRCT
TSSI
TSSI
Q1 26
Q4 25
1.34×
Q3 25
Q2 25
11.02×
Q1 25
6.93×
Q4 24
-11.32×
Q3 24
14.60×
Q2 24
-3.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

TSSI
TSSI

Procurement Revenues Segment$43.2M71%
System Integration Services Segment$14.2M23%
Facilities Segment$3.5M6%

Related Comparisons